Skip to content

COSMOS HEALTH INC.: 10-Q filed 2021-11-15

What COSMOS HEALTH INC. reported in its quarterly report filed 2021-11-15 (fiscal Q3 2021): 43 published measures, 129 facts as tagged in accession 0001477932-21-008353.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-15
Fiscal period
fiscal Q3 2021
Accession
0001477932-21-008353 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All COSMOS HEALTH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3047,677,339USD
At 2020-12-3143,844,413USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3043,026,378USD
At 2020-12-3148,005,426USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-304,650,961USD
At 2021-06-30384,548USD
At 2021-03-31-2,804,680USD
At 2020-12-31-4,161,013USD
At 2020-09-30-4,770,002USD
At 2020-06-30-5,527,750USD
At 2020-03-31-7,087,901USD
At 2019-12-31-6,460,829USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-301,033,875USD
At 2020-12-31628,395USD
At 2020-09-301,081,631USD
At 2019-12-3138,537USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,936,543USD92
2021-01-01 to 2021-09-30-6,489,502USD273
2021-04-01 to 2021-06-30-2,379,056USD91
2021-01-01 to 2021-03-31-2,173,903USD90
2020-07-01 to 2020-09-30757,866USD92
2020-01-01 to 2020-09-301,651,867USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-5,549,269USD273
2020-01-01 to 2020-09-30-10,342,115USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-30521,758USD273
2020-01-01 to 2020-09-30113,845USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-07-01 to 2021-09-3013,595,418USD92
2021-01-01 to 2021-09-3040,061,419USD273
2020-07-01 to 2020-09-3014,352,098USD92
2020-01-01 to 2020-09-3039,105,318USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-306,475,402USD273
2020-01-01 to 2020-09-3010,984,011USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-835,425USD273
2020-01-01 to 2020-09-30-113,845USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-25,240,326USD
At 2020-12-31-18,750,824USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-07-01 to 2021-09-3017,136,735shares92
2021-01-01 to 2021-09-3016,103,193shares273
2020-07-01 to 2020-09-3013,225,387shares92
2020-01-01 to 2020-09-3013,225,387shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-3017,136,735shares92
2021-01-01 to 2021-09-3016,103,193shares273
2020-07-01 to 2020-09-3013,263,944shares92
2020-01-01 to 2020-09-3013,260,518shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.11USD/shares92
2021-01-01 to 2021-09-30-0.4USD/shares273
2020-07-01 to 2020-09-300.06USD/shares92
2020-01-01 to 2020-09-300.12USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.11USD/shares92
2021-01-01 to 2021-09-30-0.4USD/shares273
2020-07-01 to 2020-09-300.06USD/shares92
2020-01-01 to 2020-09-300.12USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-07-01 to 2021-09-30168,561USD92
2021-01-01 to 2021-09-3069,152USD273
2020-07-01 to 2020-09-304,435USD92
2020-01-01 to 2020-09-3013,927USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-301,968,505USD
At 2020-12-311,757,213USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-914,551USD92
2021-01-01 to 2021-09-30-4,022,120USD273
2020-07-01 to 2020-09-301,080,003USD92
2020-01-01 to 2020-09-302,291,880USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3044,283,835USD
At 2020-12-3140,772,946USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-30670,282USD92
2021-01-01 to 2021-09-302,182,715USD273
2020-07-01 to 2020-09-30789,426USD92
2020-01-01 to 2020-09-301,853,414USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-3037,427,495USD
At 2020-12-3134,793,076USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2021-09-3049,697USD
At 2020-12-3149,697USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,260,121USD92
2021-01-01 to 2021-09-309,405,868USD273
2020-07-01 to 2020-09-301,317,307USD92
2020-01-01 to 2020-09-303,646,732USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-303,594,061USD
At 2020-12-313,292,557USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,345,570USD92
2021-01-01 to 2021-09-305,383,748USD273
2020-07-01 to 2020-09-302,397,310USD92
2020-01-01 to 2020-09-305,938,612USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3017,039,208shares
At 2020-12-3113,069,800shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3030,146,413USD
At 2020-12-3114,333,285USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-30167,386USD
At 2020-12-31854,896USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30913,541USD
At 2020-12-31833,763USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2021-09-303,020,846USD
At 2020-12-3110,771,882USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-302,835,633USD
At 2020-12-312,447,427USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-09-30458,570USD
At 2020-12-31180,809USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-30101,446USD
At 2020-12-31107,168USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-30936,134USD
At 2020-12-31742,374USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-305,912,171USD
At 2020-12-315,148,441USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,767,982USD92
2021-01-01 to 2021-09-30-6,420,350USD273
2020-07-01 to 2020-09-30762,301USD92
2020-01-01 to 2020-09-301,665,794USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-07-01 to 2020-09-30757,866USD92
2020-04-01 to 2020-06-301,377,311USD91
2020-01-01 to 2020-03-31-483,310USD91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,427,085USD92
2021-01-01 to 2021-09-306,708,796USD273
2020-07-01 to 2020-09-30543,776USD92
2020-01-01 to 2020-09-301,340,602USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-07-01 to 2021-09-3068,852USD92
2021-01-01 to 2021-09-30218,664USD273
2020-07-01 to 2020-09-3058,905USD92
2020-01-01 to 2020-09-30183,156USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-07-01 to 2021-09-308,339USD92
2021-01-01 to 2021-09-3024,746USD273
2020-07-01 to 2020-09-308,339USD92
2020-01-01 to 2020-09-3024,836USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-853,431USD92
2021-01-01 to 2021-09-30-2,398,230USD273
2020-07-01 to 2020-09-30-317,702USD92
2020-01-01 to 2020-09-30-626,086USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-5,122,888USD273
2020-01-01 to 2020-09-30-10,099,941USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-481,409USD273
2020-01-01 to 2020-09-30-727,960USD274

Inspect the source

Entity
COSMOS HEALTH INC. / CIK 0001474167
Captured
2026-09-20T09:07:57.368Z
SEC response SHA-256
f91884dcfc5ed49a155a49d6e8abdd1a5d8586cbb0334ac226e4561bd32d019e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001474167.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))